TipRanks
Advertisement
Advertisement
BioNTech, OncoC4 announce first median overall survival data from PRESERVE-003
PremiumThe FlyBioNTech, OncoC4 announce first median overall survival data from PRESERVE-003
19d ago
BioNTech downgraded to Market Perform from Outperform at BMO Capital
Premium
The Fly
BioNTech downgraded to Market Perform from Outperform at BMO Capital
25d ago
BioNTech price target lowered to $136 from $142 at Canaccord
Premium
The Fly
BioNTech price target lowered to $136 from $142 at Canaccord
1M ago
BioNTech Halts Phase 2 mRNA Monotherapy Trial in Resected Colorectal Cancer After DSMB Review
PremiumCompany AnnouncementsBioNTech Halts Phase 2 mRNA Monotherapy Trial in Resected Colorectal Cancer After DSMB Review
1M ago
BioNTech drops 9% after ending Phase 2 colorectal cancer trial
Premium
The Fly
BioNTech drops 9% after ending Phase 2 colorectal cancer trial
1M ago
BioNTech to terminate Phase 2 monotherapy trial of cevumeran
Premium
The Fly
BioNTech to terminate Phase 2 monotherapy trial of cevumeran
1M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―